2m 2m 2m 2m 2m 2m 2m
TAYSHA GENE THER (TSHA)
NASDAQ
$6.95+$0.42 (+6.46%)
Price as of Jun 23, 2026 4:47 PM EDT- $1.9BMarket Cap
- 162.25%1-Year Change
- BiotechnologyIndustry
TAYSHA GENE THER (TSHA)
$6.95+$0.42 (+6.46%)
TSHA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.53 | ||
Change | +$0.11 (+1.71%) | ||
Open | $6.50 | ||
High | $6.70 | ||
Low | $6.46 | ||
Previous Close | $6.42 | ||
Volume | 3,035,720 | ||
30-Day Average Volume | 2,622,228 | ||
1-Week Change | 9.38% | ||
1-Month Change | 18.94% | ||
1-Year Change | 162.25% | ||
3-Year Change | 812.65% | ||
5-Year Change | -74.22% | ||
Fundamentals | |||
Shares Outstanding | 287.4M | ||
Total Assets | $300.4M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$42.4M | ||
Free Cash Flow | -$40.9M | ||
EBIT | -$42.4M | ||
EBITDA | -$42.1M | ||
Net Working Capital | $262.2M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -54 | ||
PEG | 1 | ||
Price/Free Cash Flow | -46 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue